ReviewCurrent treatment options in oncology2025

The Improving Outcomes in Relapsed-Refractory Diffuse Large B Cell Lymphoma: The Role of CAR T-Cell Therapy.

Vibor Milunović et al.PubMed ↗Publisher ↗

No numbers read from the abstract.